IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release
The secretory leukocyte protease inhibitor (SLPI) is a low-molecular-weight inhibitor of proteases, such as elastase and cathepsin G which are released from leukocytes during phagocytosis. The purpose of this study was to determine whether or not SLPI is able to inhibit IgE-mediated histamine releas...
Saved in:
Main Authors: | U. Westin, E. Lundberg, K. Ohlsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1998-01-01
|
Series: | Mediators of Inflammation |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09629359891162 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Production of Secretory Leucocyte Protease Inhibitor (SLPI) in Human Pancreatic β-Cells
by: Max Nyström, et al.
Published: (1999-01-01) -
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
by: Max Nyström, et al.
Published: (2001-01-01) -
The role of exogenous histamine in atopic dermatitis flare-ups
by: Zofia Kowalska, et al.
Published: (2024-08-01) -
SALIVARY SPECIFIC IgE TO D1 AND G6 IN PATIENTS WITH RHINITIS WITH OR WITHOUT S. AUREUS COLONIZATION
by: Diana Hristova, et al.
Published: (2025-01-01) -
Validated HPLC method for simultaneous determination of azelastine hydrochloride fluticasone propionate and oxymetazoline in nasal mucosa and nasopharyngeal swabs from real human samples
by: Neven N. Mikawy, et al.
Published: (2025-02-01)